Helixmith Co., Ltd Logo

Helixmith Co., Ltd

084990 | KO

Overview

Corporate Details

ISIN(s):
KR7084990001
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로7길 21, 강서구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-09 00:00
AGM Information
임시주주총회결과
Korean 6.1 KB
2025-06-19 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 51.3 KB
2025-06-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 15.2 KB
2025-06-18 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 48.4 KB
2025-05-16 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.1 MB
2025-05-15 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-15 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 5.7 KB
2025-05-02 00:00
Legal Proceedings Report
소송등의판결ㆍ결정 (주주총회소집허가)
Korean 6.2 KB
2025-03-27 00:00
AGM Information
정기주주총회결과
Korean 22.0 KB
2025-03-27 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.1 KB

Automate Your Workflow. Get a real-time feed of all Helixmith Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Helixmith Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Helixmith Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.